Literature DB >> 21274652

A comparison of antibiotic point prevalence survey data from four Irish regional/general hospitals.

C Naughton1, Y Hennessy, C Mannion, M Philbin.   

Abstract

INTRODUCTION: Point prevalence surveys (PPS) are increasingly used to examining and compare hospital antibiotic consumption. The aim of this study was to identify the (1) point prevalence of antibiotic use in one regional hospital and (2) compare PPS data from similar regional/general hospitals.
METHODS: Data were collected on all inpatients with an active antibiotic prescription and on all prescriptions issued in the emergency department over a 24-h period. Point prevalence data were obtained from three other regional/general hospitals.
RESULTS: The frequency of antibiotic use was hospital A = 29%, B = 38%, C = 34% and D = 37%. Overall, the most commonly prescribed antibiotic was co-amoxiclav (30%), followed by macrolides (12%). However, new generation broad-spectrum antibiotics, such as piperacillin/tazobactam or ciprofloxacin, were also commonly used. Prescribing for common conditions such as respiratory infection or cellulites showed diverse antibiotic selection.
CONCLUSION: Point prevalence survey data using a standardised methodology could facilitate both local audit and national benchmarking to monitor antibiotic use.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21274652     DOI: 10.1007/s11845-011-0677-5

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  11 in total

Review 1.  Can better prescribing turn the tide of resistance?

Authors:  David Livermore
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

2.  Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001-2002.

Authors:  W V Kern; Katja de With; Michaela Steib-Bauert; M Fellhauer; A Plangger; W Probst
Journal:  Infection       Date:  2005-10       Impact factor: 3.553

Review 3.  European status of resistance in nosocomial infections.

Authors:  Herman Goossens
Journal:  Chemotherapy       Date:  2005-07-06       Impact factor: 2.544

4.  Benchmarking antimicrobial drug use at university hospitals in five European countries.

Authors:  V Vlahović-Palcevski; U Dumpis; P Mitt; J Gulbinovic; J Struwe; G Palcevski; D Stimac; A Lagergren; U Bergman
Journal:  Clin Microbiol Infect       Date:  2007-03       Impact factor: 8.067

5.  A RCT evaluating the effectiveness and cost-effectiveness of academic detailing versus postal prescribing feedback in changing GP antibiotic prescribing.

Authors:  Corina Naughton; John Feely; Kathleen Bennett
Journal:  J Eval Clin Pract       Date:  2009-10       Impact factor: 2.431

6.  Drug utilization 90%--a simple method for assessing the quality of drug prescribing.

Authors:  U Bergman; C Popa; Y Tomson; B Wettermark; T R Einarson; H Aberg; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1998-04       Impact factor: 2.953

Review 7.  Optimizing antibiotic prescribing in primary care settings in the UK: findings of a BSAC multi-disciplinary workshop 2009.

Authors:  Cliodna A M McNulty; Nick A Francis
Journal:  J Antimicrob Chemother       Date:  2010-09-30       Impact factor: 5.790

Review 8.  Interventions to improve antibiotic prescribing practices in ambulatory care.

Authors:  S R Arnold; S E Straus
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

9.  The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006.

Authors:  Faranak Ansari; Mats Erntell; Herman Goossens; Peter Davey
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

10.  Antimicrobial use in Finnish acute care hospitals: data from national prevalence survey, 2005.

Authors:  Mari Kanerva; Jukka Ollgren; Outi Lyytikäinen
Journal:  J Antimicrob Chemother       Date:  2007-06-05       Impact factor: 5.790

View more
  2 in total

1.  Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005-2014.

Authors:  P J Stapleton; D J Lundon; R McWade; N Scanlon; M M Hannan; F O'Kelly; M Lynch
Journal:  Ir J Med Sci       Date:  2017-01-04       Impact factor: 1.568

2.  Antimicrobial Use at Acute Care Hospitals in Nova Scotia: A Point Prevalence Survey.

Authors:  Emily Black; Heather Neville; Mia Losier; Megan Harrison; Kim Abbass; Kathy Slayter; Lynn Johnston; Ingrid Sketris
Journal:  Can J Hosp Pharm       Date:  2018-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.